288 related articles for article (PubMed ID: 33386568)
1. A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.
Rui ZY; Liu Y; Zheng W; Wang X; Meng ZW; Tan J; Li N; Jia Q
Clin Exp Med; 2021 May; 21(2):277-286. PubMed ID: 33386568
[TBL] [Abstract][Full Text] [Related]
2. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
3. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
[TBL] [Abstract][Full Text] [Related]
4. A prediction model incorporating the BRAF
Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
6. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
7. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
[TBL] [Abstract][Full Text] [Related]
8. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Ye L; Hu L; Liu W; Luo Y; Li Z; Ding Z; Hu C; Wang L; Zhu Y; Liu L; Ma X; Kong Y; Huang L
BMC Cancer; 2021 Nov; 21(1):1250. PubMed ID: 34800991
[TBL] [Abstract][Full Text] [Related]
9. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
11. The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma.
Yan XQ; Ma ZS; Zhang ZZ; Xu D; Cai YJ; Wu ZG; Zheng ZQ; Xie BJ; Cao FL
Front Endocrinol (Lausanne); 2022; 13():937870. PubMed ID: 35957824
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study.
Gong J; Zhu B; Liu W; Shi C; Xia C; Zeng L; Lv Y
Horm Metab Res; 2023 May; 55(5):315-322. PubMed ID: 36934720
[TBL] [Abstract][Full Text] [Related]
13. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
Shao L; Wang Z; Dong W; Sun W; Zhang H
Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
[TBL] [Abstract][Full Text] [Related]
18. Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.
Zou Y; Zhang H; Li W; Guo Y; Sun F; Shi Y; Gong Y; Lu X; Wang W; Xia S
BMC Cancer; 2021 Mar; 21(1):221. PubMed ID: 33663422
[TBL] [Abstract][Full Text] [Related]
19. Distinct risk factors of lateral lymph node metastasis in patients with papillary thyroid cancer based on age stratification.
Cai H; Zhuge L; Huang Z; Wang S; Shi P; Yan D; Niu L; Li Z
BMC Surg; 2024 Jan; 24(1):24. PubMed ID: 38218911
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
Zhao L; Sun X; Luo Y; Wang F; Lyu Z
Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
